Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2012

Aug 21, 2012

6990_dirs_2012-08-21_38d13955-60e9-4fad-be86-089d5bee1cdb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2012-08-17

Reporting Person: YANAY YAKY (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-17 Common Stock S 16927 $5 Disposed 769616 Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to automatic selling under Rule 10b5-1 trading plan adopted by the reporting person as amended on May 15, 2012.